Uncategorized
Ocular TherapeutixTM to Present at Two Upcoming Investor Conferences
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences: 2016 RBC Capital Markets Global Healthcare ConferenceWednesday, February 24, 2016 at 4:05 p.m. Eastern TimeThe New York Palace Hotel, New York, NY 36th A
